A detailed history of Citigroup Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Citigroup Inc holds 5,601 shares of FHTX stock, worth $45,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,601
Previous 3,385 65.47%
Holding current value
$45,200
Previous $22,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.05 - $8.0 $11,190 - $17,728
2,216 Added 65.47%
5,601 $32,000
Q1 2024

May 10, 2024

BUY
$2.82 - $7.94 $1,274 - $3,588
452 Added 15.41%
3,385 $22,000
Q4 2023

Feb 09, 2024

BUY
$2.94 - $6.76 $7,020 - $16,142
2,388 Added 438.17%
2,933 $18,000
Q3 2023

Nov 09, 2023

SELL
$5.0 - $9.87 $31,165 - $61,519
-6,233 Reduced 91.96%
545 $2,000
Q2 2023

Aug 10, 2023

BUY
$5.37 - $8.84 $33,836 - $55,700
6,301 Added 1320.96%
6,778 $47,000
Q1 2023

May 11, 2023

SELL
$4.66 - $8.99 $876 - $1,690
-188 Reduced 28.27%
477 $2,000
Q4 2022

Feb 09, 2023

BUY
$5.44 - $9.46 $1,958 - $3,405
360 Added 118.03%
665 $4,000
Q3 2022

Nov 10, 2022

SELL
$7.52 - $18.01 $7,474 - $17,901
-994 Reduced 76.52%
305 $3,000
Q2 2022

Aug 10, 2022

BUY
$8.48 - $16.84 $4,036 - $8,015
476 Added 57.84%
1,299 $18,000
Q1 2022

May 12, 2022

SELL
$8.87 - $22.1 $36,934 - $92,024
-4,164 Reduced 83.5%
823 $13,000
Q4 2021

Feb 10, 2022

BUY
$10.79 - $22.87 $29,737 - $63,029
2,756 Added 123.53%
4,987 $114,000
Q3 2021

Nov 10, 2021

BUY
$8.33 - $15.02 $18,584 - $33,509
2,231 New
2,231 $31,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.